Digital Health Startups

Joyous provides ketamine-assisted mental health treatment focused on patient accessibility and well-being. The company delivers in-person and technology-supported care for depression and related conditions, operating as a Public Benefit Corporation headquartered in Silicon Valley.

1 investor

JSLink is a biotechnology company specializing in genomic analysis services and personalized medicine, with growing operations in rare-earth permanent magnet manufacturing. The company combines genomics research with biomarker discovery and bioinformatics analysis to support drug development and personalized medical treatment.

1 investor

Juisci provides scientific literature monitoring and content generation tools for healthcare organizations including medical associations, hospitals, and life science companies. The platform helps these organizations stay current with research, create educational content, and engage with medical practitioners.

1 investor

P95 Julius Clinical is a contract research organization that conducts clinical trials and real-world evidence programs for biotech and pharmaceutical companies, with expertise in neuroscience, infectious diseases, vaccines, and cardiovascular and metabolic diseases. The company operates globally across 25+ countries with over 500 professionals.

1 investor

Jumuia Hospitals is a Kenyan healthcare provider offering 24-hour hospital services including general medicine, maternity, surgery, dental, optical, imaging, orthopedics, laboratory, and pharmacy care. It also runs tele-health and a surgical referral app connecting patients nationwide to its surgical services.

1 investor

Junction Health partners with Federally Qualified Health Centers (FQHCs) to set up and manage IV infusion therapy sites, expanding access to infusion services for chronically ill, uninsured, Medicaid, and underserved patients across the US. It handles program implementation and operations while helping health centers improve financial sustainability and patient access to specialty medications.

1 investor

Jupiter Neurosciences is a biopharmaceutical company developing JOTROL, a patented micellar oral formulation of resveratrol designed to cross the blood-brain barrier for central nervous system treatment. Its focus is developing therapies for Alzheimer's disease and rare "orphan" diseases.

1 investor

Jura Health offers at-home genetic testing (saliva or cheek swab) with telehealth genetic counseling to diagnose rare diseases, delivering results in about five weeks along with guidance on next steps. It serves patients and families seeking answers about undiagnosed rare conditions.

1 investor

Kadence Bio is a clinical-stage life sciences company developing therapeutics for conditions in sexual and mental health. Its lead asset, KH-001, is being developed as an FDA-approved treatment for premature ejaculation, alongside a pipeline of compounds targeting mood disorders.

1 investor

Kahani is a voice-based, AI companion app that provides daily check-ins, activities, and empathetic conversations to support people in recovery, including those dealing with eating disorders, body image, and food-related behaviors. Users choose a personality and tone, set goals, and track their progress over time.

1 investor

Kai provides therapist-led, AI-supported mental health and emotional wellbeing support delivered through messaging apps like WhatsApp and iMessage, combining daily AI chats with oversight from licensed therapists. It serves employers, clinics, universities, municipalities, and individuals with features such as mood tracking, daily check-ins, and stress relief tools.

1 investor

KAI provides AI-powered conversation analysis for pharmaceutical and healthcare professionals, using acoustic, linguistic, and visual intelligence to uncover emotional insights and improve communication between pharma field teams and healthcare providers, and between clinicians and patients.

1 investor

Kailos Genetics is a biotechnology company with expertise in medical and biotechnology industries.

1 investor

Kalexo Bio develops dual-targeting siRNA therapeutics for cardiovascular disease, with a focus on lipid management and atherosclerotic disease prevention. The company's lead program targets genetic drivers of cardiovascular risk to deliver durable risk reduction in patients.

1 investor

Kalia Health is a biotechnology startup developing a home-based urine test that detects elevated protein levels to screen for preeclampsia and eclampsia early in pregnancy. It targets women's and maternal healthcare for low-resource settings in the United States and globally.

1 investor

Kama is a science-based mobile and web app offering guided breath, body and touch practices for desire, arousal, pleasure and connection, along with interviews on topics like libido, shame and intimacy. It is aimed at individuals and couples for use solo or with a partner.

1 investor

Triage Wallet is a digital document and profile management platform for healthcare travel professionals, enabling them to store compliance documents, manage career information, and streamline job applications and onboarding processes.

1 investor

Kaminari Medical develops intravascular imaging technology for cardiovascular interventions, using photoacoustic and optical innovations. The company serves interventional cardiologists and vascular surgeons for real-time imaging during catheter-based procedures.

1 investor

Tunstall is a provider of health and social care services and technology solutions for elderly care and personal emergency response services across Europe and Asia-Pacific. The company serves healthcare providers, local governments, and individuals requiring care and safety services.

1 investor

Kando builds a unified platform that connects nurse-call systems, assistants, hardware, and software for care environments such as nursing homes and senior residences, aiming to reduce staff administrative workload and improve patient safety. It develops its own proprietary AI models, hardware, and software, operated in Europe with HDS hosting and GDPR compliance.

1 investor

A clinical-stage life sciences company developing therapeutics for unmet needs in sexual and mental health, including a lead program aimed at becoming the first FDA-approved treatment for premature ejaculation and a pipeline targeting mood disorders.

1 investor

Kannact is a human-driven digital health company that provides support services to help people achieve better health outcomes. The company focuses on patient engagement and care coordination for health improvement.

1 investor

Kantoko operates a telehealth platform connecting adults with ADHD specialists for remote diagnosis and treatment planning in Australia. The company aims to improve access to ADHD care by reducing wait times and costs while expanding into other healthcare specialties.

1 investor

Kanurra operates a transparent pharmacy benefit management (PBM) service for self-funded employers, charging a flat per-employee-per-month administrative fee while passing drug costs through at actual cost with full rebate transparency. The company eliminates hidden markups, retained rebates, and formulary kickbacks that characterize legacy PBMs.

1 investor